Seigla Medical

Seigla Medical is a medical technology company based in Minnesota, founded in December 2017. The company specializes in developing innovative solutions for treating vascular diseases, particularly in the peripheral, cardiovascular, and neurovascular areas. Their mission is to enhance patient outcomes by addressing the challenges faced by interventional physicians through superior engineering and manufacturing capabilities. The company offers advanced guide catheters designed for complex Percutaneous Coronary Intervention (PCI) procedures. These catheters feature an 18% larger lumen and a 45% thinner wall compared to conventional options, improving performance in challenging cases. One of their notable products is the liquID Guide Catheter Extension®, which allows for the extension of the guide catheter while maintaining the preferred vascular access point. This product has received FDA clearance and meets rigorous safety and performance standards. Seigla Medical's products are distributed globally, targeting interventional cardiologists and vascular specialists who require advanced catheter technologies for complex procedures. The leadership team includes Chad Kugler, President and CEO, and John Schultz, Acting VP of Clinical Affairs, both of whom bring extensive experience in the medical industry.

• Employees 5
• Founded 2017
• Total Funding $350000